SCHEMBL7984880

SCHEMBL7984880

O=c1nc(-c2ccccc2F)[nH]c2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.46
YTHDC1 Q96MU7 3/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
GLA P06280 1/20 0.44
HTT P42858 1/20 0.44
UBE2N P61088 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ACP1 P24666 1/20 0.43
PARN O95453 1/20 0.43
CNOT7 Q9UIV1 1/20 0.43
MAPK1 P28482 3/20 0.42
CXCR2 P25025 2/20 0.41
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
FSCN1 Q16658 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974647 0.91 CNOT7 (0.51) P2RX7SMN1; SMN2HTTACP1PARN
SCHEMBL7988457 0.90 PARN (0.42) P2RX7SMN1; SMN2UBE2NACP1PARN
SCHEMBL7974312 0.88 HPGD (0.45) P2RX7SMN1; SMN2HTTACP1PARN
SCHEMBL7988188 0.86 CNOT7 (0.44) P2RX7SMN1; SMN2HTTL3MBTL1ACP1
SCHEMBL7988669 0.85 PARN (0.48) P2RX7YTHDC1SMN1; SMN2GLAHTT
SCHEMBL7985875 0.85 TP53 (0.48) P2RX7YTHDC1HPGDGRIN1GRIN2B
SCHEMBL7988820 0.85 MAPK1 (0.48) P2RX7YTHDC1SMN1; SMN2GLAHTT
SCHEMBL7974061 0.85 CNOT7 (0.42) P2RX7SMN1; SMN2GLAHTTL3MBTL1
SCHEMBL7973628 0.84 SMN1; SMN2 (0.48) P2RX7YTHDC1SMN1; SMN2GLAHTT
SCHEMBL7984876 0.84 SMN1; SMN2 (0.47) P2RX7YTHDC1SMN1; SMN2GLAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed